India clinical trial to evaluate efficacy of glutathione therapy for early Alzheimer's Disease

Titled "Impact of Glutathione (GSH) Supplementation in Mild Cognitive Impairment (MCI) Patients: A Randomized Control Trial", the study is funded by the Department of Biotechnology (DBT), approved by the Drugs Controller General of India and is listed on Clinical Trials Registry-India (CTRI).

Related Keywords

Pennsylvania ,United States ,Melbourne ,Victoria ,Australia ,India ,Pravat Mandal ,Ashley Bush ,Bush Is Mental Health Clinical ,University Of Melbourne ,University Of Pittsburgh Medical Center ,Mental Health ,While The Alzheimer Association ,Department Of Biotechnology ,University Of Pittsburgh ,Florey Institute Of Neuroscience ,National Brain Research Centre ,Mild Cognitive Impairment ,Randomized Control ,Drugs Controller General ,Clinical Trials Registry India ,Pittsburgh Medical Center ,Florey Institute ,Mental Health Clinical ,